Evidence map›Paper›PMID 31217301›Full record

ArticlemSphere2019

Questionable Efficacy of Therapeutic Antibodies in the Treatment of Anthrax.

Jean-Nicolas Tournier, Clémence Rougeaux, Fabrice V Biot, Pierre L Goossens

Open access · goldAbstract read
In one paragraph

Article in mSphere, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Anthrax revisited: how assessing the unpredictable can improve biosecurity.Frontiers in bioengineering and biotechnology · 2023
    Article
  5. PathogenicPathogens (Basel, Switzerland) · 2022
    Review
  6. Article
  7. Review
  8. Article
  9. You Can'tFrontiers in microbiology · 2020
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Jean-Nicolas TournierInstitut de Recherche Biomédicale des Armées, Bacteriology, Anti-infectious Biotherapies, and Immunity Unit, Brétigny-sur-Orge, France jntournier.irba@gmail.com.ORCID 0000-0002-4542-2421
Clémence RougeauxInstitut de Recherche Biomédicale des Armées, Bacteriology, Anti-infectious Biotherapies, and Immunity Unit, Brétigny-sur-Orge, France.
Fabrice V BiotInstitut de Recherche Biomédicale des Armées, Bacteriology, Anti-infectious Biotherapies, and Immunity Unit, Brétigny-sur-Orge, France.ORCID 0000-0002-3632-2146
Pierre L GoossensInstitut de Recherche Biomédicale des Armées, Bacteriology, Anti-infectious Biotherapies, and Immunity Unit, Brétigny-sur-Orge, France.
Institut de Médecine Tropicale du Service de Santé des Armées · FRCentre National de la Recherche Scientifique · FRInstitut Pasteur · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inhalational anthrax caused by

Indexed as

ImmunotherapyAnimalsAnthraxAntibodies, BacterialAntibodies, MonoclonalAntigens, BacterialAntitoxinsBacillus anthracisBacterial ToxinsDisease Models, AnimalDrug Evaluation, PreclinicalHumansRespiratory Tract InfectionsAntibodies, BacterialAntibodies, MonoclonalAntigens, BacterialAntitoxinsBacterial Toxinsanthraxantitoxinsmonoclonal antibodiesprotective antigentoxins

Identifiers

PMID31217301
PMCPMC6584371
OpenAlexW2950437449

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.